0001415889-23-014037.txt : 20231006 0001415889-23-014037.hdr.sgml : 20231006 20231006162641 ACCESSION NUMBER: 0001415889-23-014037 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231004 FILED AS OF DATE: 20231006 DATE AS OF CHANGE: 20231006 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Megna Michael R CENTRAL INDEX KEY: 0001464583 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38492 FILM NUMBER: 231314514 MAIL ADDRESS: STREET 1: 1050 HINGHAM STREET CITY: ROCKLAND STATE: MA ZIP: 02370 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Kiniksa Pharmaceuticals, Ltd. CENTRAL INDEX KEY: 0001730430 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: D0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: CLARENDON HOUSE STREET 2: 2 CHURCH STREET CITY: HAMILTON STATE: D0 ZIP: HM11 BUSINESS PHONE: 7814399100 MAIL ADDRESS: STREET 1: CLARENDON HOUSE STREET 2: 2 CHURCH STREET CITY: HAMILTON STATE: D0 ZIP: HM11 4 1 form4-10062023_081034.xml X0508 4 2023-10-04 0001730430 Kiniksa Pharmaceuticals, Ltd. KNSA 0001464583 Megna Michael R C/O KINIKSA PHARMACEUTICALS, LTD. CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM 11 BERMUDA false true false false CHIEF ACCOUNTING OFFICER 0 Class A Common Share 2023-10-04 4 M 0 175 A 17057 D Class A Common Share 2023-10-04 4 F 0 52 16.01 D 17005 D Restricted Share Unit 2023-10-04 4 M 0 175 0 D Class A Common Share 175 350 D Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. The RSUs vest over a four year period, with 25% of the RSUs vesting on each anniversary of the date of grant, October 4, 2021. /s/ Madelyn Zeylikman, Attorney-in-Fact 2023-10-06